Is HIV-1 infection associated with endothelial dysfunction in a population of African ancestry in South Africa?

Cardiovascular Journal of Africa

Volumn 22, Issue 3, 2011, Pages 134-140

  Fourie, C ^a   Van Rooyen, J ^a   Pieters, M ^a   Conradie, K ^a   Hoekstra, T ^b   Schutte, A ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Endothelial dysfunction; HIV 1; Inflammation; Never treated; South Africa; Vascular aging

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING DISORDER; BODY MASS; CAROTID ARTERY PULSE; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEGRO; PROTEIN BLOOD LEVEL; SOUTH AFRICA; SYSTOLIC BLOOD PRESSURE;

EID: 79959682751     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2010-056     Document Type: Article

References (51)

1. Lee YW, Eum SY, Nath A, Toborek M. Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells. Cardiovasc Res 2004; 63(1): 139-148. (Pubitemid 38759818)
2. Fisher SD, Miller TL, Lipshultz SE. Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. Atherosclerosis 2006; 185(1): 1-11. (Pubitemid 43117545)
3. Constans J, Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta 2006; 368(1-2): 33-47. (Pubitemid 43792418)
4. Hsue PY, Lo JC, Franklin A et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004; 109(13): 1603-1608. (Pubitemid 38451715)
5. Glazier JJ, Spears JR, Murphy MC. Interventional approach to recurrent myocardial infarction in HIV-1 infection. J Interv Cardiol 2006; 19(1): 93-98.
6. Sliwa K, Wilkinson D, Hansen C, et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008; 371(9616): 915-922. (Pubitemid 351375275)
7. UNAIDS Sub-Saharan Africa. Aids epidemic update. Regional Summary 2008. Accessed March 2009. http://data.unaids.org/pub/Report/2008/jc1526-epibriefs- ssafrica-en.pdf.
8. Coll B, van Wijk JP, Parra S, et al. Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy. Eur J Pharmacol 2006; 544(1-3): 104-110. (Pubitemid 44164451)
9. Schillaci G, De Socio GV, Pucci G, et al. Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension 2008; 52(2): 308-313.
10. Andrade AC, Cotter BR. Endothelial function and cardiovascular diseases in HIV infected patient. Braz J Infect Dis 2006; 10(2): 139-145. (Pubitemid 44194339)
11. De Larranaga GF, Bocassi AR, Puga LM, et al. Endothelial markers and HIV infection in the era of highly active antiretroviral treatment. Thromb Res 2003; 110(2-3): 93-98. (Pubitemid 37329447)
12. Wu JT, Wu LL. Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment. Clin Chim Acta 2006; 366(1-2): 74-80. (Pubitemid 43330968)
13. Lorenz MW, Stephan C, Harmjanz A, et al. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis 2008; 196(2): 720-726.
14. Jacobs GB, de Beer C, Fincham JE, et al. Serotyping and genotyping of HIV-1 infection in residents of Khayelitsha, Cape Town, South Africa. J Med Virol 2006; 78(12): 1529-1536. (Pubitemid 44672493)
15. Peeters M. The genetic variability of HIV-1 and its implications. Transfus Clin Biol 200; 8(3): 222-225.
16. Gaschen B, Taylor J, Yusim K, et al. Diversity considerations in HIV-1 vaccine selection. Science 2002; 296(5577): 2354-2360. (Pubitemid 34734202)
17. Freire E. Overcoming HIV-1 resistance to protease inhibitors. Drug Discovery 2006; 3(2): 281-286. (Pubitemid 44356304)
18. Bessong PO, Larry OC, Cilliers T et al. Characterization of human immunodeficiency virus type 1 from a previously unexplored region of South Africa with a high HIV prevalence. AIDS Res Hum Retroviruses 2005; 21(1): 103-109. (Pubitemid 40179807)
19. Coll B, Parra S, Alonso-Villaverde C, et al. HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: the role of monocyte chemoattractant protein-1. Cytokine 2006; 34(1-2): 51-55. (Pubitemid 43817552)
20. de Gaetano DK, Rabagliati R, Iacoviello L, Cauda R. HIV infection, HAART, and endothelial adhesion molecules: current perspectives. Lancet Infect Dis 2004; 4(4): 213-222.
21. Masia M, Bernal E, Padilla S, et al. The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients. Atherosclerosis 2007; 195(1): 167-171. (Pubitemid 47569983)
22. Teo K, Chow CK, Vaz M, et al. The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 2009; 158: 1-7.
23. World Medical Association Declaration of Helsinki. Ethical principles for Medical Research Involving Human Subjects. http://www.wma.net/e/policy/b3.htm. Aaccessed February 2009.
24. ISAK - International Society for the Advancement of Kinanthropometry (ISAK). International standards for anthropometric assessment. Adelaide: National Library of Australia; 2001: 133.
25. Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62(5): 707-714. (Pubitemid 8110784)
26. Zhang Y, Zanotti I, Reilly MP, et al. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation 2003; 108(6): 661-663. (Pubitemid 36999247)
27. Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res 2006; 98(11): 1352-1364. (Pubitemid 43948059)
28. Barter PJ, Nicholls S, Rye KA, et al. Anti-inflammatory properties of HDL. Circ Res 2004; 95(8): 764-772.
29. Negre-Salvayre A, Dousset N, Ferretti G, et al. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Radic Biol Med 2006; 41(7): 1031-1040. (Pubitemid 44348872)
30. Patel S, Puranik R, Nakhla S, et al. Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the antiinflammatory capacity of high density lipoproteins. Atherosclerosis 2009; 204(2): 424-428.
31. Wadham C, Albanese N, Roberts J, et al. High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation 2004; 109(17): 2116-2122. (Pubitemid 38620221)
32. De Ferranti SD, Rifai N. C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc Pathol 2007; 16(1): 14-21. (Pubitemid 46049026)
33. O'Brien KD, McDonald TO, Chait A, et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996; 93(4): 672-682. (Pubitemid 26052452)
34. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340(2): 115-26. (Pubitemid 29054847)
35. Dhawan S, Puri RK, Kumar A, et al. Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 1997; 90(4): 1535-1544. (Pubitemid 27355425)
36. Liu K, Chi DS, Li C, et al. HIV-1 Tat protein-induced VCAM-1 expression in human pulmonary artery endothelial cells and its signaling. Am J Physiol Lung Cell Mol Physiol 2005; 289(2): L252-L260. (Pubitemid 41008907)
37. Cohn JN. Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens 2001; 14(8 Pt 2): 258S-263S.
38. Alpert BS, Collins RT. Assessment of vascular function: pulse wave velocity. J Pediatr 2007; 150(3): 219-220. (Pubitemid 46328976)
39. van Wijk JP, de Koning EJ, Cabezas MC, et al. Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol 2006; 47(6): 1117-1123.
40. Safar H, Mourad JJ, Safar M, Blacher J. Aortic pulse wave velocity, an independent marker of cardiovascular risk. Cardiovasc Res 2002; 95: 1215-1218. (Pubitemid 36091020)
41. O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007; 50(1): 1-13. (Pubitemid 46963521)
42. Cameron JD, Bulpitt CJ, Pinto ES, Rajkumar C. The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. Diabetes Care 2003; 26(7): 2133-2138. (Pubitemid 41184264)
43. Dart AM, Kingwell BA. Pulse pressure-a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001; 37(4): 975-984. (Pubitemid 32217593)
44. Norata GD, Catapano AL. Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium. Vasc Health Risk Manag 2005; 1(2): 119-129.
45. Lijfering WM, Sprenger HG, Georg RR, et al. Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection. Clin Chem 2008; 54(7): 1226-1233. (Pubitemid 352009700)
46. Koppel K, Bratt G, Schulman S, et al. Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 29(5): 441-449. (Pubitemid 34456334)
47. James S, Vorster HH, Venter CS, et al. Nutritional status influences plasma fibrinogen concentration: evidence from the THUSA survey. Thromb Res 2000; 98(5): 383-394. (Pubitemid 30319311)
48. Vorster HH, Jerling JC, Steyn K, et al. Plasma fibrinogen of black South Africans: the BRISK study. Public Health Nutr 1998; 1(3): 169-176. (Pubitemid 128548290)
49. Holzemer WL, Uys L, Makoae L, et al. A conceptual model of HIV/AIDS stigma from five African countries. J Adv Nurs 2007; 58(6): 541-551.
50. Greeff M, Phetlhu R, Makoae LN, et al. Disclosure of HIV status: experiences and perceptions of persons living with HIV/AIDS and nurses involved in their care in Africa. Qual Health Res 2008; 18(3): 311-324. (Pubitemid 351201341)
51. Kruger A, Greeff M, Watson MJ, Fourie CMT. Health care seeking behaviour of newly diagnosed HIV infected people from rural and urban communities in the North West province of South Africa. Afr J Nurs Midwifery 200; 11(2): 30-47.